Items where Division is "Current Faculties > Faculty of Medicine > School of Healthcare, Enterprise and Innovation > SHTAC
School of Healthcare, Enterprise and Innovation > SHTAC" and Year is 2022
 | Up a level |
Number of items: 20.
Article
Core Outcome Measures for Perioperative and Anaesthetic Care (COMPAC): a modified Delphi process to develop a core outcome set for trials in perioperative care and anaesthesia - Oliver Boney, S. Ramani Moonesinghe, Paul S. Myles, Michael P.W. Grocott, J. Bartoszko and W. S. Beattie
Type: Article
| 2022
| Item not available on this server.
ACCEPT - combining acalabrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) for Diffuse Large B-cell Lymphoma (DLBCL): study protocol for a Phase Ib/II open-label non-randomised clinical trial - Andrew Davies, Sharon Barrans, Cathy Burton, Katy Mercer, Joshua Caddy, Fay Chinnery, Laura Day, Diana Fernando, Kirit Ardeshna, Graham Collins, John Radford, Simon Rule, Andrew Mcmillan, Peter Johnson and Gareth Griffiths
Type: Article
| 2022
Principles and framework for assessing the risk of bias for studies included in comparative quantitative environmental systematic reviews - Geoff Frampton, Paul Whaley, Micah Bennett, Gary Bilotta, Jean-Lou CM Dorne, Jacqualyn Eales, Katy James, Christian Kohl, Magnus Land, Barbara Livoreil, David Makowski, Evans Muchiri, Gillian Petrokofsky, Nicola Randall and Kate Schofield
Type: Article
| 2022
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease - Hugh G. Gallagher, Jennifer S. Dumbleton, Thomas Maishman, Amy L Whitehead, Michael Moore, Ahmet Fuat, David A. Fitzmaurice, Robert A. Henderson, Joanne Lord, Kathryn E Griffith, Paul Stevens, Maarten W. Taal, Diane Stevenson, Simon Fraser, Mark Lown, Christopher J Hawkey and Paul Roderick
Type: Article
| 2022
Cost-effectiveness of a dietary and physical activity intervention in adolescents: a prototype modelling study based on the Engaging Adolescents in Changing Behaviour (EACH-B) programme. - Neelam Kalita, Keith Cooper, Janis Baird, Kathryn Woods-Townsend, Keith Godfrey, Cyrus Cooper, Hazel Inskip, Mary Barker and Joanne Lord
Type: Article
| 2022
Health-related quality of life, fatigue and health utilities in lupus nephritis: a systematic literature review - Saifuddin Kharawala, Gavneet Kaur, Hemlata Shukla and David Alexander Scott
Type: Article
| 2022
| Item not available on this server.
Self-sampling to identify pathogens and inflammatory markers in patients with acute sore throat: feasibility study - Mark Lown, Elizabeth A. Miles and Helena L. Fisk
Type: Article
| 2022
Parental perceptions and experiences of infant crying: a systematic review and synthesis of qualitative research - Ingrid Muller, Daniela Ghio, Jasmine Mobey, Hannah Jones, Samantha Hornsey, Amy Elizabeth Dobson, Emma Maund and Miriam Santer
Type: Article
| 2022
Duodenal-jejunal bypass liner for the management of type 2 diabetes mellitus and obesity: A multicenter randomized controlled trial - Aruchuna Ruban, Alexander D Miras, Michael A Glaysher, Anthony P Goldstone, Christina G Prechtl, Nicholas Johnson, Navpreet Chhina, Werd Al-Najim, Madhawi Aldhwayan, Natalia Klimowska-Nassar, Claire Smith, Joanne Lord, Jia V Li, Lilliam Flores, Moaz Al-Lababidi, Georgios K Dimitriadis, Mayank Patel, Michael Moore, Harvinder Chahal, Ahmed R Ahmed, Jonathan Cousins, Ghadah Aldubaikhi, Ben Glover, Emanuela Falaschetti, Hutan Ashrafian, Carel W le Roux, Ara Darzi, James P Byrne and Julian P Teare
Type: Article
| 2022
The economic burden of Lupus Nephritis: a systematic literature review - Juliette C Thompson, Anadi Mahajan, David A Scott and Kerry Gairy
Type: Article
| 2022
Monograph
Type: Monograph
| 2022
| Collaboration for Environmental Evidence
| Item not available on this server.
Nintedanib for treating idiopathic pulmonary fibrosis in people with a forced vital capacity above 80% predicted (part-review of technology appraisal guidance 379): a single technology appraisal - Keith Cooper, Lorna Hazell, Asyl Hawa, Joanna Picot, Fay Chinnery, David Alexander Scott and Jonathan Shepherd
Type: Monograph
| 2022
| National Institute for Health and Care Research
| Item not available on this server.
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency: A highly specialised technology appraisal - Neelam Kalita, Inês Souto Ribeiro, Karen Pickett, Emma Maund, Lois Woods, David Alexander Scott, Asyl Hawa and Joanne Lord
Type: Monograph
| 2022
| National Institute for Health and Care Research
Cemiplimab for treating cutaneous squamous cell carcinoma (CDF review TA592) - Neelam Kalita, Lois Woods, Joanne Lord and Geoff Frampton
Type: Monograph
| 2022
| National Institute for Health and Care Research
Ruxolitinib for treating polycythaemia vera: a single technology appraisal - Joanne Lord, Lois Woods, Asyl Hawa, David Alexander Scott and Geoff Frampton
Type: Monograph
| 2022
| National Institute for Health and Care Research
Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma: a single technology appraisal - Emma Maund, Keith Cooper, Marcia Tomie Takahashi and Jonathan Shepherd
Type: Monograph
| 2022
| National Institute for Health and Care Research
Avalglucosidase alfa for treating Pompe disease - Ines Ribeiro, Emma Maund, Keith Cooper, Karen Pickett, Marcia Tomie Takahashi, David Alexander Scott and Jonathan Shepherd
Type: Monograph
| 2022
| National Institute for Health and Care Research
Dataset
Type: Dataset
| 2022
| figshare
| Item not available on this server.
Letter
Standards of conduct and reporting in evidence syntheses that could inform environmental policy and management decisions - Andrew S Pullin, Samantha H Cheng, Josephine D'Urban Jackson, Jacqualyn Eales, Ida Envall, Salamutu J Fada, Geoff Frampton, Meagan Harper, Andrew N Kadykalo, Christian Kohl, Ko Konno, Barbara Livoreil, Dakis‑Yaoba Ouédraogo, Bethan C O'Leary, George Pullin, Nicola Randall, Rebecca Rees, Adrienne Smith, Romain Sordello, Eleanor J Sterling, Will M Twardek and Paul Woodcock
Type: Letter
| 2022
Review
How does risdiplam compare with other treatments for Types 1-3 spinal muscular atrophy: a systematic literature review and indirect treatment comparison - Valerie Aponte Ribero, Monica Daigl, Yasmina Martí, Ksenija Gorni, Rachel Evans, David Alexander Scott, Anadi Mahajan, Keith R Abrams and Neil Hawkins
Type: Review
| 2022